| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0097 | 0.8 |